Search research articles
Contact Us
Filters
Showing results (561-570 of 616) with videos related to
Page
of 62
Sort By:
Journal of the American College of Cardiology
|
November 22, 2023
Semaglutide in Patients With Obesity and Heart Failure Across Mildly Reduced or Preserved Ejection Fraction
Javed Butler, Steen Z Abildstrøm, Barry A Borlaug, et al.
The Canadian Journal of Cardiology
|
August 12, 2022
2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults
G B John Mancini, Eileen O'Meara, Shelley Zieroth, et al.
Cardiovascular Diabetology
|
July 31, 2025
Efficacy and safety of dapagliflozin in patients hospitalized with COVID-19 with and without type 2 diabetes: a prespecified analysis of the DARE-19 randomized trial
Mohammad Abdel Jawad, Remo H M Furtado, Russell Esterline, et al.
European Journal of Heart Failure
|
December 28, 2020
Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA-HF
Pooja Dewan, Kieran F Docherty, Olof Bengtsson, et al.
The Lancet. Diabetes & Endocrinology
|
February 17, 2025
Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial
Rahul Aggarwal, Deepak L Bhatt, Michael Szarek, et al.
Journal of the American College of Cardiology
|
November 20, 2024
Sodium Zirconium Cyclosilicate for Management of Hyperkalemia During Spironolactone Optimization in Patients With Heart Failure
Mikhail N Kosiborod, David Z I Cherney, Akshay S Desai, et al.
European Journal of Heart Failure
|
June 26, 2024
Geographical variation in patient characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction
Mingming Yang, Toru Kondo, Pardeep S Jhund, et al.
European Journal of Heart Failure
|
April 29, 2025
The efficacy of finerenone on hierarchical composite endpoint analysed using win statistics in patients with heart failure and mildly reduced or preserved ejection fraction: A prespecified analysis of FINEARTS-HF
Toru Kondo, Pardeep S Jhund, Alasdair D Henderson, et al.
European Heart Journal
|
May 7, 2025
Clinical staging to guide management of metabolic disorders and their sequelae: a European Atherosclerosis Society consensus statement
Stefano Romeo, Antonio Vidal-Puig, Mansoor Husain, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
June 3, 2024
Association between overweight and obesity with coronary artery bypass graft failure: an individual patient data analysis of clinical trials
Kevin R An, Sigrid Sandner, Björn Redfors, et al.
Page
of 62
Search research articles
Search
Showing results (561-570 of 616) with videos related to
Sort By:
Page
of 62
Journal of the American College of Cardiology
|
November 22, 2023
Semaglutide in Patients With Obesity and Heart Failure Across Mildly Reduced or Preserved Ejection Fraction
Javed Butler, Steen Z Abildstrøm, Barry A Borlaug, et al.
The Canadian Journal of Cardiology
|
August 12, 2022
2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults
G B John Mancini, Eileen O'Meara, Shelley Zieroth, et al.
Cardiovascular Diabetology
|
July 31, 2025
Efficacy and safety of dapagliflozin in patients hospitalized with COVID-19 with and without type 2 diabetes: a prespecified analysis of the DARE-19 randomized trial
Mohammad Abdel Jawad, Remo H M Furtado, Russell Esterline, et al.
European Journal of Heart Failure
|
December 28, 2020
Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA-HF
Pooja Dewan, Kieran F Docherty, Olof Bengtsson, et al.
The Lancet. Diabetes & Endocrinology
|
February 17, 2025
Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial
Rahul Aggarwal, Deepak L Bhatt, Michael Szarek, et al.
Journal of the American College of Cardiology
|
November 20, 2024
Sodium Zirconium Cyclosilicate for Management of Hyperkalemia During Spironolactone Optimization in Patients With Heart Failure
Mikhail N Kosiborod, David Z I Cherney, Akshay S Desai, et al.
European Journal of Heart Failure
|
June 26, 2024
Geographical variation in patient characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction
Mingming Yang, Toru Kondo, Pardeep S Jhund, et al.
European Journal of Heart Failure
|
April 29, 2025
The efficacy of finerenone on hierarchical composite endpoint analysed using win statistics in patients with heart failure and mildly reduced or preserved ejection fraction: A prespecified analysis of FINEARTS-HF
Toru Kondo, Pardeep S Jhund, Alasdair D Henderson, et al.
European Heart Journal
|
May 7, 2025
Clinical staging to guide management of metabolic disorders and their sequelae: a European Atherosclerosis Society consensus statement
Stefano Romeo, Antonio Vidal-Puig, Mansoor Husain, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
June 3, 2024
Association between overweight and obesity with coronary artery bypass graft failure: an individual patient data analysis of clinical trials
Kevin R An, Sigrid Sandner, Björn Redfors, et al.
Page
of 62